Evidence map›Paper›PMID 35424802›Full record

ArticleRSC advances2022

X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution.

Marcin Ziemniak, Sylwia Pawlędzio, Anna Zawadzka-Kaźmierczuk, Paulina M Dominiak, Damian Trzybiński, Wiktor Koźmiński, Rafał Zieliński, Izabela Fokt, Waldemar Priebe, Krzysztof Woźniak and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Marcin ZiemniakBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw Zwirki i Wigury 101 02-089 Warszawa Poland mziemniak@chem.uw.edu.pl spawledzio@chem.uw.edu.pl anzaw@chem.uw.edu.pl dtrzybinski@chem.uw.edu.pl kozmin@chem.uw.edu.pl kwozniak@chem.uw.edu.pl.
Sylwia PawlędzioBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw Zwirki i Wigury 101 02-089 Warszawa Poland mziemniak@chem.uw.edu.pl spawledzio@chem.uw.edu.pl anzaw@chem.uw.edu.pl dtrzybinski@chem.uw.edu.pl kozmin@chem.uw.edu.pl kwozniak@chem.uw.edu.pl.
Anna Zawadzka-KaźmierczukBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw Zwirki i Wigury 101 02-089 Warszawa Poland mziemniak@chem.uw.edu.pl spawledzio@chem.uw.edu.pl anzaw@chem.uw.edu.pl dtrzybinski@chem.uw.edu.pl kozmin@chem.uw.edu.pl kwozniak@chem.uw.edu.pl.ORCID 0000-0002-1125-7923
Paulina M DominiakBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw Zwirki i Wigury 101 02-089 Warszawa Poland mziemniak@chem.uw.edu.pl spawledzio@chem.uw.edu.pl anzaw@chem.uw.edu.pl dtrzybinski@chem.uw.edu.pl kozmin@chem.uw.edu.pl kwozniak@chem.uw.edu.pl.ORCID 0000-0002-1466-1243
Damian TrzybińskiBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw Zwirki i Wigury 101 02-089 Warszawa Poland mziemniak@chem.uw.edu.pl spawledzio@chem.uw.edu.pl anzaw@chem.uw.edu.pl dtrzybinski@chem.uw.edu.pl kozmin@chem.uw.edu.pl kwozniak@chem.uw.edu.pl.ORCID 0000-0003-3920-5532
Wiktor KoźmińskiBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw Zwirki i Wigury 101 02-089 Warszawa Poland mziemniak@chem.uw.edu.pl spawledzio@chem.uw.edu.pl anzaw@chem.uw.edu.pl dtrzybinski@chem.uw.edu.pl kozmin@chem.uw.edu.pl kwozniak@chem.uw.edu.pl.ORCID 0000-0003-2319-4525
Rafał ZielińskiDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center 1901 East Rd. Houston TX 77054 USA rziel77@gmail.com ifokt@mdanderson.org wpriebe@mac.com.
Izabela FoktDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center 1901 East Rd. Houston TX 77054 USA rziel77@gmail.com ifokt@mdanderson.org wpriebe@mac.com.
Waldemar PriebeDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center 1901 East Rd. Houston TX 77054 USA rziel77@gmail.com ifokt@mdanderson.org wpriebe@mac.com.
Krzysztof WoźniakBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw Zwirki i Wigury 101 02-089 Warszawa Poland mziemniak@chem.uw.edu.pl spawledzio@chem.uw.edu.pl anzaw@chem.uw.edu.pl dtrzybinski@chem.uw.edu.pl kozmin@chem.uw.edu.pl kwozniak@chem.uw.edu.pl.ORCID 0000-0002-0277-294X
Beata PająkIndependent Laboratory of Genetics and Molecular Biology, Kaczkowski Military Institute of Hygiene and Epidemiology Kozielska 4 01-163 Warsaw Poland bepaj@wp.pl.ORCID 0000-0002-3565-8860
University of Warsaw · PLThe University of Texas MD Anderson Cancer Center · USWojskowy Instytut Higieny i Epidemiologii · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structural studies on two bromo-substituted derivatives of 2-deoxy-d-glucose (2-DG), namely 2-deoxy-2-bromo-d-glucose (2-BG) and 2-deoxy-2-bromo-d-mannose (2-BM) are described. 2-DG itself is an inhibitor of hexokinase, the first enzyme in the glycolysis process, playing a vital role in both cancer cell metabolism and viral replication in host cells. Because of that, 2-DG derivatives are considered as potential anti-cancer and anti-viral drugs. An X-ray quantum crystallography approach allowed us to obtain more accurate positions of hydrogen atoms by applying Hirshfeld atom refinement, providing a better description of hydrogen bonding even in the case of data from routine X-ray experiments. Obtained structures showed that the introduction of bromine at the C2 position in the pyranose ring has a minor influence on its conformation but still, it has a noticeable effect on the crystal structure. Bromine imposes the formation of a layered supramolecular landscape containing hydrogen bonds, which involves the bromine atom. Periodic DFT calculations of cohesive and interaction energies (at the B3LYP level of theory) have supported these findings and highlighted energetic changes upon bromine substitution. Based on molecular wavefunction from the refinement, we calculated the electrostatic potential, Laplacian, and ELI-D, and applied them to charge-density studies, which confirmed the geometry of hydrogen bonding and involvement of the bromine atom with these intermolecular interactions. NMR studies in the solution show that both compounds do not display significant differences in their anomeric equilibria compared to 2-DG, and the pyranose ring puckering is similar in both aqueous and solid state.

Identifiers

PMID35424802
PMCPMC8985090
OpenAlexW4224135705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.